The present study demonstrated that investigating both anti-BP180 and anti-type VII collagen antibodies serum concentrations was useful to exclude EBA diagnosis in BP patients with mucosal involvement at time of diagnosis. The gene discussed is COL17A1; the disease is acquired epidermolysis bullosa.